Luo Y - Search Results

1

Concomitant genetic alterations are associated with response to EGFR targeted therapy in patients with lung adenocarcinoma.

Chen H, Liu M, Dai Z, Li S, Luo Y, Wang Y, Su W, Cai W, Yang D, Huang J, Yang Z. Chen H, et al. Among authors: luo y. Transl Lung Cancer Res. 2020 Aug;9(4):1225-1234. doi: 10.21037/tlcr-20-679. Transl Lung Cancer Res. 2020. PMID: 32953500 Free PMC article.

2

Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib.

Wang Y, Tang D, Sui A, Jiao W, Luo Y, Wang M, Yang R, Wang Z, Shen Y. Wang Y, et al. Among authors: luo y. Clin Transl Oncol. 2013 May;15(5):384-90. doi: 10.1007/s12094-012-0939-3. Epub 2012 Oct 11. Clin Transl Oncol. 2013. PMID: 23065601

3

CUG-binding protein 1 (CUGBP1) expression and prognosis of non-small cell lung cancer.

Jiao W, Zhao J, Wang M, Wang Y, Luo Y, Zhao Y, Tang D, Shen Y. Jiao W, et al. Among authors: luo y. Clin Transl Oncol. 2013 Oct;15(10):789-95. doi: 10.1007/s12094-013-1005-5. Epub 2013 Jan 29. Clin Transl Oncol. 2013. PMID: 23359188

4

[MiR-373-3p Promotes Invasion and Metastasis of Lung Adenocarcinoma Cells].

Wu A, Li J, Wu K, Mo Y, Luo Y, Ye H, Shen X, Li S, Liang Y, Liu M, Yang Z. Wu A, et al. Among authors: luo y. Zhongguo Fei Ai Za Zhi. 2015 Jul;18(7):427-35. doi: 10.3779/j.issn.1009-3419.2015.07.07. Zhongguo Fei Ai Za Zhi. 2015. PMID: 26182868 Free PMC article. Chinese.

5

Down-regulation of miR-133a as a poor prognosticator in non-small cell lung cancer.

Wang Y, Li J, Chen H, Mo Y, Ye H, Luo Y, Guo K, Mai Z, Zhang Y, Chen B, Zhou Y, Yang Z. Wang Y, et al. Among authors: luo y. Gene. 2016 Oct 15;591(2):333-7. doi: 10.1016/j.gene.2016.06.001. Epub 2016 Jun 6. Gene. 2016. PMID: 27282282

6

LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.

Wu A, Li J, Wu K, Mo Y, Luo Y, Ye H, Mai Z, Guo K, Wang Y, Li S, Chen H, Luo W, Yang Z. Wu A, et al. Among authors: luo w, luo y. Biomed Pharmacother. 2016 Aug;82:290-7. doi: 10.1016/j.biopha.2016.04.008. Epub 2016 May 17. Biomed Pharmacother. 2016. PMID: 27470365

7

miR-135b reverses chemoresistance of non-small cell lung cancer cells by downregulation of FZD1.

Su W, Mo Y, Wu F, Guo K, Li J, Luo Y, Ye H, Guo H, Li D, Yang Z. Su W, et al. Among authors: luo y. Biomed Pharmacother. 2016 Dec;84:123-129. doi: 10.1016/j.biopha.2016.09.027. Epub 2016 Sep 16. Biomed Pharmacother. 2016. PMID: 27643554

8

Concurrent versus sequential whole brain radiotherapy and TKI in EGFR-mutated NSCLC patients with brain metastasis: A single institution retrospective analysis.

Chen H, Wu A, Tao H, Yang D, Luo Y, Li S, Yang Z, Chen M. Chen H, et al. Among authors: luo y. Medicine (Baltimore). 2018 Nov;97(44):e13014. doi: 10.1097/MD.0000000000013014. Medicine (Baltimore). 2018. PMID: 30383657 Free PMC article.

9

Activation of the Hedgehog pathway mediates resistance to epidermal growth factor receptor inhibitors in non-small cell lung cancer.

Chen H, Yang D, Wang Y, Tao H, Luo Y, Wu A, Li S, Yang Z, Chen M. Chen H, et al. Among authors: luo y. J Cancer. 2022 Jan 4;13(3):987-997. doi: 10.7150/jca.63410. eCollection 2022. J Cancer. 2022. PMID: 35154464 Free PMC article.

10

Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression.

Chen HL, Luo YP, Lin MW, Peng XX, Liu ML, Wang YC, Li SJ, Yang DH, Yang ZX. Chen HL, et al. Cancer Med. 2022 Jul;11(13):2627-2643. doi: 10.1002/cam4.4638. Epub 2022 Mar 28. Cancer Med. 2022. PMID: 35347894 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,798 results

Search Page

Filters